Dr. Reddy's Laboratories, Incorporated

Dr. Reddy's Research Foundation

Reddy-cheminor, Inc.

Other

Reddy's Laboratories Ltd.

Redd's Research Foundation

Reddy's Research Foundation

Ranjan Chakrabarti

Rajagopalan Ramanujam

Braj Bhushan Lohray

Vidya Bhushan Lohray

Rao Bheema Paraselli

Ranga Madhavan Gurram

Shivaramayya Kalchar

Ashok Channaveerappa Bajji

Javed Iqbal

Saibal Kumar Das

Venkateswarlu Akella

Sekar Reddy Alla

Parimal Misra

Sarma K S Pakala

Gurram Ranga Madhavan

Sriram K Rajagopal

Srinivas Nanduri

Sairam Pothukuchi

Reeba Kannimel Vikramadithyan

Bhuniya Debnath

Sarma Ks Pakala

Sunilkumar Bhadramma Kochunarayana Pillai

Pradip Kumar Sasmal

Vijay Potluri

Ashok Bajji

Ramanujam Rajagopalan

Gurram Ranga Madhaven

Mamillapalli Ramabadhra Sarma

Sreenivas Dharmaraja Rao

Chebiyyam Prabhakar

Debnath Bhunia

Krishnamurthi Vyas

Sarma K Pakala

Paraselli Bheema Rao

Rashmi Talwar

Papi Reddy Purma

Debnath Bhuniya

Om Gaddam Reddy

The present application provides novel thiazole derivatives that are useful as activators of Adenosine 5'-Monophosphate-Activated Protein Kinase and pharmaceutical compositions containing such compounds.

Thiazoles derivatives as AMPK activator

The present invention relates to novel antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds of formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them.

Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them

The present invention relates to novel antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds of formula (I) their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them, to a process for preparing such compounds. More particularly, the present invention relates to novel alkyl carboxylic acids of the general, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them, to a process for preparing such compounds. The present invention also relates to processes for the preparation of the compounds of formula (I), novel intermediates, processes for their preparation, their use in the preparation of the above said compounds and their use as antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds 

Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them

The present invention relates to novel hypolipidemic, antihyperglycemic compounds, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. More particularly, the present invention relates to novel &#x3b2;-aryl-&#x3b1;-oxysubstituted alkylcarboxylic acids of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. 

Monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them

The present invention relates to novel antiobesity and hypocholesterolemic compounds, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. More particularly, the present invention relates to novel &#x3b2;-aryl-&#x3b1;-oxysubstituted alkylcarboxylic acids of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. The present invention also relates to a process for the preparation of the above said novel compounds, their analogs, their derivatives, their tautomeric forms, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. The present invention also relates to novel intermediates, processes for their preparation and their use in the preparation of compounds of formula (I).

Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them

Novel &#x3b2;-aryl-&#x3b1;-oxysubstituted alkylcarboxylic acids of the formula (I) and compositions containing them.  The compounds have hypolipidemic, antihyperglycemic uses.

Tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them

The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel azolidinedione derivatives of the general formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them.

Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases

Novel &#x3b2;-aryl-&#x3b1;-oxysubstituted alkylcarboxylic acids of the formula (I) and compositions containing them.The compounds have hypolipidemic, antihyperglycemic uses.

Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them

Compounds of formula (I)its tautomeric forms, its stereoisomers, its polymorphs, its pharmaceutically acceptable salts or its pharmaceutically acceptable solvates can be used to prevent or treat diabetes caused by insulin resistance or impaired glucose tolerance or complications of diabetes caused by insulin resistance or impaired glucose tolerance. The compounds can also be used to reduce cholesterol, body weight, blood glucose, triglycerides and free fatty acids in the blood.

Bicyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them

The present invention relates to novel anticancer agents, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, and their pharmaceutically acceptable solvates. The present invention more particularly relates to novel derivatives of andrographolide, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, and their pharmaceutically acceptable solvates. The novel derivatives of andrographolide have the general formula (I).

Anticancer compounds: process for their preparation and pharmaceutical compositions containing them

Growing community of inventors

Hyderabad Telangana, India

Ranjan Chakrabarti